Comanche Biopharma

Concord, United States

Our purpose is to make every pregnancy around the world safer.

$75.0M raised

Jan 2024

Series B

Biopharma Biotechnology Pharmaceutical

Top Investors

New Enterprise AssociatesLilly Asia VenturesF-Prime CapitalAtlas VentureGoogle Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Comanche Biopharma

How much funding has Comanche Biopharma raised?

Comanche Biopharma has raised $75.0M in total funding. The most recent round was Series B. The last funding was announced in January 2024.

Who are Comanche Biopharma's investors?

Comanche Biopharma's investors include New Enterprise Associates, Lilly Asia Ventures, F-Prime Capital, Atlas Venture, Google Ventures.

Where is Comanche Biopharma headquartered?

Comanche Biopharma is headquartered in Concord, United States.

What does Comanche Biopharma do?

Our purpose is to make every pregnancy around the world safer.

What stage is Comanche Biopharma at?

Comanche Biopharma is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 17, 2024.

MLA

"Comanche Biopharma — Funding & Investors." VCBacked, January 17, 2024, https://www.vcbacked.co/company/comanche-biopharma. Accessed June 4, 2026.

APA

VCBacked. (2024). Comanche Biopharma — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/comanche-biopharma

Wikipedia (cite web)

{{cite web |title=Comanche Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/comanche-biopharma |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 17, 2024.

Similar Companies in Biopharma